Nuclear Imaging Equipment Market Size, Share, Industry, Forecast and Outlook (2023-2030)

<h2>Nuclear Imaging Equipment Market is segmented By Product (Positron Emission Tomography (PET) Systems, Positron Emission Tomography/Computed Tomography (PET/CT) Systems, Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Systems, Single Photon Emission Computed Tomography (SPECT) Systems, Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) Systems)&nbsp;By Application (Oncology, Cardiology, Neurology, Others)&nbsp;By End-users (Hospitals,&nbsp;Imaging Centers,&nbsp;Academic &amp; Research Centers,&nbsp;Others) and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2023-2030</h2>

<h3>Market Overview</h3>

<blockquote>
The Global Nuclear Imaging Equipment Market reached US$ YY&nbsp;million in 2022 and is expected to reach US$ YY&nbsp;million by 2030, growing with a CAGR of YY% during the forecast period 2023-2030.
</blockquote>

Nuclear imaging technology, commonly referred to as nuclear medicine imaging equipment, is a highly developed imaging instrument used in the field of nuclear medicine to observe and evaluate numerous physiological structures and processes within the human body. These devices provide images of inside organs, tissues, and physiological processes using minute quantities of radioactive substances (radiotracers or radiopharmaceuticals).&nbsp;

Nuclear imaging technology is essential for the detection and monitoring of a number of illnesses, such as cancer, heart disease, neurological problems, and abnormalities of the bones. The equipment selected relies on the particular clinical application and the data that healthcare professionals need. These machines, which are used by qualified radiologists and nuclear medicine technologists, are essential to contemporary healthcare.

<h3>Market Scope</h3>

<table cellspacing="0" style="border-collapse:collapse">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Metrics
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #8eaadb; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Details
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			CAGR
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			YY%
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Size Available for Years
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2021-2030
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Forecast Period
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2023-2030
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Data Availability
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Value (US$)&nbsp;
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Segments Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Product, Application and End-user
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Regions Covered
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America, Europe, Asia-Pacific, South America and Middle East &amp; Africa
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Fastest Growing Region
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Asia-Pacific
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Largest Region
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Report Insights Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.
			</td>
		</tr>
	</tbody>
</table>

&nbsp;

For more details on this report - <a href="https://www.datamintelligence.com/download-sample/nuclear-imaging-equipment-market" target="_blank">Request for Sample</a>

<h3>&nbsp;</h3>

<h3>Market Dynamics</h3>

Increasing Research Activities

As of June 2023, Serac Imaging Systems, a UK-based firm, developed a portable high-resolution hybrid gamma optical camera, which is currently undergoing clinical trials in the United States. The Seracam imaging device trial is anticipated to involve 25 participants and last about six months. The Ohio State University Wexner Medical Center is the second location to start an investigator-sponsored study to compare gamma images obtained using Seracam with those captured using a current state-of-the-art gamma camera for nuclear medical imaging, from the same patient on the same day, following testing in Kuala Lumpur, Malaysia.&nbsp;

The device uses radiation to scan radioisotopes, which are given to the patient, in a manner similar to that used in satellites used in X-ray astronomy, which was first created by the University of Leicester. This exposes details on how the body functions, such as whether there are any blockages.

Technological Advancements

As per the article published in the European Journal of Nuclear Medicine and Molecular Imaging in 2023, the newest PET/MRI systems, such as those with silicon photomultiplier (SiPM) detectors and time of flight (TOF) capabilities, offer sensitivity levels that are higher than those of traditional devices. Additionally, MRI technology developments like synthetic MRI and fingerprinting technologies, together with artificial intelligence reconstruction approaches, have a lot of potential for use in research settings. These advancements may shorten the time it takes for an MRI to acquire data while still enabling functional and anatomical imaging.&nbsp;

However, it is crucial to keep in mind that the imminent introduction of a new generation of PET/MRI devices will transform the scene. These new systems are anticipated to have a number of improvements, including improved MRI systems using bigger magnets and larger diameter bores, wider axial coverage, and hence increased PET sensitivity. Additionally, these new devices will come with specialized AI software developed to speed up clinical throughput using cutting-edge imaging sequences. Shorter acquisition periods (25&ndash;30 min) and increased MRI sensitivity will follow from this.

High Cost

Healthcare facilities must make a substantial upfront capital investment in nuclear imaging equipment like PET and SPECT scanners. This price covers the cost of the imaging system itself, installation, and any infrastructure alterations required to make room for the apparatus. Nuclear imaging equipment includes ongoing maintenance and operational expenditures in addition to the initial purchase. To ensure the accuracy and dependability of the equipment, this also includes routine servicing and calibration.

The use of radiopharmaceuticals in nuclear imaging procedures raises the overall cost even if they are not a part of the equipment cost. The price of radiopharmaceuticals can be high and varies according to the particular tracer that is employed.

Radiation Exposure Concerns

During nuclear imaging operations, radioactive substances known as radiopharmaceuticals or tracers are used. These substances generate ionizing radiation. The removal of strongly bonded electrons from atoms by ionizing radiation has sufficient energy to possibly harm biological tissues. When the radiopharmaceutical is administered to patients undergoing nuclear imaging, they are exposed to ionizing radiation.&nbsp;

Depending on the procedure type and the particular radiopharmaceutical employed, different radiation exposure levels apply. Although the risk is normally modest, there is still some risk involved. Patients may experience many nuclear imaging treatments throughout time, particularly if they have ongoing medical issues that need to be monitored. Radiation exposure over time might be a worry, especially for people who have imaging frequently.

&nbsp;

For more details on this report &ndash; Request for Sample&nbsp;

<h2>&nbsp;</h2>

<h3>Segment Analysis</h3>

The global nuclear imaging equipment market is segmented based on product, application, end-user and region.

The PET/CT segment accounted for approximately 45.7% of the market share&nbsp;

As per the Article published in Stat Pearls in 2023, PET/CT (positron emission tomography) is a commonly utilized nuclear medicine imaging method used to examine the staging, therapy response, or recurrence of many malignancies. In addition to mammography, which is still the primary imaging test for identifying and screening cancer, other secondary imaging modalities include ultrasound, MRI, and, under some circumstances, PET/CT. This activity examines the use of PET/CT as an additional imaging technique for the evaluation of breast cancer patients. Furthermore, the interprofessional team&#39;s use of PET/CT in the context of breast cancer is highlighted in this activity, along with the indications, imaging method, patient preparation, and use of PET/CT.&nbsp;

The physiological and biochemical information offered by PET is greatly enhanced by the anatomical information provided by CT. It is possible to acquire fused pictures with the combined information on a single screen and to blend from one to the other by modifying the 922 (color) scales thanks to the 919 combining of the two modalities into PET/CT by positioning the two system gantries on a 920 common axis and with a common patient bed.

<h3>Geographical Penetration</h3>

North America segment accounted for approximately 38.9% of the market share&nbsp;

North America has been a dominant force in the global nuclear imaging equipment market. Nuclear imaging technology is constantly improving, resulting in more accurate and effective imaging, which has fueled market expansion. Particularly common hybrid imaging technologies are PET/CT and PET/MRI, which are used for diagnosis. For instance, in June 2023,&nbsp;at the 2023 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), GE HealthCare plans to introduce SIGNA PET/MR AIR[i]. The business will demonstrate how its cutting-edge AIR technologies may be integrated with the SIGNA PET/MR AIR system to improve diagnostic accuracy, streamline therapy evaluation, and improve patient comfort.&nbsp;&nbsp;

The need for dependable and comprehensive imaging solutions across the patient care journey is highlighted by recent FDA approvals of innovative PET radiotracers and therapeutic methods for high-prevalence disorders like prostate cancer and Alzheimer&#39;s Disease. SIGNA PET/MR AIR incorporates distinct GE HealthCare AIR technologies that respond to the changing needs of specific patient populations. These innovations include MotionFree Brain[ii], which reduces motion-related PET picture degradation, AIR Coils, which increases and improves patient comfort, AIR Recon DL, which improves MR image quality and enables scan time reduction, and AIR Coils.&nbsp;&nbsp;

<h3>COVID-19 Impact Analysis</h3>

The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global nuclear imaging equipment market. Many optional nuclear imaging scans and other non-essential medical procedures were delayed or stopped during the early stages of the pandemic in order to lower the risk of viral transmission and save money on medical services.&nbsp;

This resulted in a sharp decline in the number of nuclear imaging procedures, which had financial repercussions for healthcare facilities and nuclear imaging equipment producers. In order to deal with the increase in COVID-19 cases, healthcare organizations changed their focus. Due to this, healthcare workers, resources, and attention were diverted from tasks unrelated to COVID-19, such as nuclear imaging. Infrastructure developments and investments in new imaging technology were occasionally postponed or cancelled.

<h3>Competitive Landscape</h3>

The major global players in the market include Siemens Healthcare GmbH, GE Healthcare, Philips Healthcare, Canon Medical Systems Corp, Serac Imaging Systems Ltd, Neusoft Medical Systems Co Ltd., DIGIRAD HEALTH, INC., Mediso Ltd., PerkinElmer, and MILabs B.V.

<h3>Key Developments</h3>

<ul>
	<li>At Arab Health 2023 in Dubai, United Imaging, a Chinese company, and I-ONE Nuclear Medicine &amp; Oncology Center have partnered to conduct the first research and development of the PET/MR uPMR 790 in the Gulf countries.</li>
</ul>

<h3>Why Purchase the Report?</h3>

<ul>
	<li>To visualize the global nuclear imaging equipment market segmentation based on product, application, end-user and region as well as understand critical commercial assets and players.</li>
	<li>Identify commercial opportunities by analyzing trends and co-development.&nbsp;</li>
	<li>Excel data sheet with numerous data points of nuclear imaging equipment market-level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping available as excel consisting of key products of all the major players.</li>
</ul>

The global nuclear imaging equipment market report would provide approximately 61 tables, 61 figures and 186 Pages.

<h3>Target Audience 2023</h3>

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>

<ol>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Definition and Overview</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Executive Summary</h3>

	<ol>
		<li>Snippet by Product</li>
		<li>Snippet by Application</li>
		<li>Snippet by End-user</li>
		<li>Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Dynamics</h3>

	<ol>
		<li>Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Increasing Research Activities</li>
				<li>Technological Advancements</li>
			</ol>
			</li>
			<li>Restraints
			<ol>
				<li>High Cost</li>
				<li>Radiation Exposure Concerns</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&#39;s Five Force Analysis&nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Russia-Ukraine War Impact Analysis</li>
		<li>DMI Opinion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of COVID-19
		<ol>
			<li>Scenario Before COVID</li>
			<li>Scenario During COVID</li>
			<li>Scenario Post COVID</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Product</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Attractiveness Index, By Product&nbsp;</li>
		</ol>
		</li>
		<li>Positron Emission Tomography (PET) Systems*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Positron Emission Tomography/Computed Tomography (PET/CT) Systems</li>
		<li>Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Systems</li>
		<li>Single Photon Emission Computed Tomography (SPECT) Systems</li>
		<li>Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) Systems&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Application</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Attractiveness Index, By Application&nbsp;</li>
		</ol>
		</li>
		<li>Oncology*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Cardiology</li>
		<li>Neurology</li>
		<li>Others&nbsp;&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By End-user</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user</li>
			<li>Market Attractiveness Index, By End-user</li>
		</ol>
		</li>
		<li>Hospitals*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Imaging Centers&nbsp;</li>
		<li>Academic &amp; Research Centers&nbsp;</li>
		<li>Others&nbsp;&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application&nbsp;</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application&nbsp;</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>UK</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application&nbsp;</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia-Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application&nbsp;</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia-Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application&nbsp;</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Company Profiles</h3>

	<ol>
		<li>Siemens Healthcare GmbH*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>GE Healthcare</li>
		<li>Philips Healthcare</li>
		<li>Canon Medical Systems Corp</li>
		<li>Serac Imaging Systems Ltd</li>
		<li>Neusoft Medical Systems Co Ltd.</li>
		<li>DIGIRAD HEALTH, INC.</li>
		<li>Mediso Ltd.</li>
		<li>PerkinElmer</li>
		<li>MILabs B.V.&nbsp;(LIST NOT EXHAUSTIVE)&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Appendix</h3>

	<ol>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

List of Tables

Table 1 Global Nuclear Imaging Equipment Market Value, By Product, 2022, 2026 &amp; 2030 (US$ Million)

Table 2 Global Nuclear Imaging Equipment Market Value, By Application, 2022, 2026 &amp; 2030 (US$ Million)

Table 3 Global Nuclear Imaging Equipment Market Value, By End-user, 2022, 2026 &amp; 2030 (US$ Million)

Table 4 Global Nuclear Imaging Equipment Market Value, By Region, 2022, 2026 &amp; 2030 (US$ Million)

Table 5 Global Nuclear Imaging Equipment Market Value, By Product, 2022, 2026 &amp; 2030 (US$ Million)

Table 6 Global Nuclear Imaging Equipment Market Value, By Product, 2021-2030 (US$ Million)

Table 7 Global Nuclear Imaging Equipment Market Value, By Application, 2022, 2026 &amp; 2030 (US$ Million)

Table 8 Global Nuclear Imaging Equipment Market Value, By Application, 2021-2030 (US$ Million)

Table 9 Global Nuclear Imaging Equipment Market Value, By End-user, 2022, 2026 &amp; 2030 (US$ Million)

Table 10 Global Nuclear Imaging Equipment Market Value, By End-user, 2021-2030 (US$ Million)

Table 11 Global Nuclear Imaging Equipment Market Value, By Region, 2022, 2026 &amp; 2030 (US$ Million)

Table 12 Global Nuclear Imaging Equipment Market Value, By Region, 2021-2030 (US$ Million)

Table 13 North America Nuclear Imaging Equipment Market Value, By Product, 2021-2030 (US$ Million)

Table 14 North America Nuclear Imaging Equipment Market Value, By Application, 2021-2030 (US$ Million)

Table 15 North America Nuclear Imaging Equipment Market Value, By End-user, 2021-2030 (US$ Million)

Table 16 North America Nuclear Imaging Equipment Market Value, By Country, 2021-2030 (US$ Million)

Table 17 South America Nuclear Imaging Equipment Market Value, By Product, 2021-2030 (US$ Million)

Table 18 South America Nuclear Imaging Equipment Market Value, By Application, 2021-2030 (US$ Million)

Table 19 South America Nuclear Imaging Equipment Market Value, By End-user, 2021-2030 (US$ Million)

Table 20 South America Nuclear Imaging Equipment Market Value, By Country, 2021-2030 (US$ Million)

Table 21 Europe Nuclear Imaging Equipment Market Value, By Product, 2021-2030 (US$ Million)

Table 22 Europe Nuclear Imaging Equipment Market Value, By Application, 2021-2030 (US$ Million)

Table 23 Europe Nuclear Imaging Equipment Market Value, By End-user, 2021-2030 (US$ Million)

Table 24 Europe Nuclear Imaging Equipment Market Value, By Country, 2021-2030 (US$ Million)

Table 25 Asia-Pacific Nuclear Imaging Equipment Market Value, By Product, 2021-2030 (US$ Million)

Table 26 Asia-Pacific Nuclear Imaging Equipment Market Value, By Application, 2021-2030 (US$ Million)

Table 27 Asia-Pacific Nuclear Imaging Equipment Market Value, By End-user, 2021-2030 (US$ Million)

Table 28 Asia-Pacific Nuclear Imaging Equipment Market Value, By Country, 2021-2030 (US$ Million)

Table 29 Middle East &amp; Africa Nuclear Imaging Equipment Market Value, By Product, 2021-2030 (US$ Million)

Table 30 Middle East &amp; Africa Nuclear Imaging Equipment Market Value, By Application, 2021-2030 (US$ Million)

Table 31 Middle East &amp; Africa Nuclear Imaging Equipment Market Value, By End-user, 2021-2030 (US$ Million)

Table 32 Siemens Healthcare GmbH: Overview

Table 33 Siemens Healthcare GmbH: Product Portfolio

Table 34 Siemens Healthcare GmbH: Key Developments

Table 35 GE Healthcare: Overview

Table 36 GE Healthcare: Product Portfolio

Table 37 GE Healthcare: Key Developments

Table 38 Philips Healthcare: Overview

Table 39 Philips Healthcare: Product Portfolio

Table 40 Philips Healthcare: Key Developments

Table 41 Canon Medical Systems Corp: Overview

Table 42 Canon Medical Systems Corp: Product Portfolio

Table 43 Canon Medical Systems Corp: Key Developments

Table 44 Serac Imaging Systems Ltd: Overview

Table 45 Serac Imaging Systems Ltd: Product Portfolio

Table 46 Serac Imaging Systems Ltd: Key Developments

Table 47 Neusoft Medical Systems Co Ltd.: Overview

Table 48 Neusoft Medical Systems Co Ltd.: Product Portfolio

Table 49 Neusoft Medical Systems Co Ltd.: Key Developments&nbsp;&nbsp;

Table 50 DIGIRAD HEALTH, INC.: Overview

Table 51 DIGIRAD HEALTH, INC.: Product Portfolio

Table 52 DIGIRAD HEALTH, INC.: Key Developments&nbsp;&nbsp;

Table 53 Mediso Ltd.: Overview

Table 54 Mediso Ltd.: Product Portfolio

Table 55 Mediso Ltd.: Key Developments&nbsp;&nbsp;

Table 56 PerkinElmer: Overview

Table 57 PerkinElmer: Product Portfolio

Table 58 PerkinElmer: Key Developments&nbsp;&nbsp;

Table 59 MILabs B.V.: Overview

Table 60 MILabs B.V.: Product Portfolio

Table 61 MILabs B.V.: Key Developments&nbsp;&nbsp;&nbsp;

List of Figures

Figure 1 Global Nuclear Imaging Equipment Market Value, 2021-2030 (US$ Million)

Figure 2 Global Nuclear Imaging Equipment Market Share, By Product, 2022 &amp; 2030 (%)

Figure 3 Global Nuclear Imaging Equipment Market Share, By Application, 2022 &amp; 2030 (%)

Figure 4 Global Nuclear Imaging Equipment Market Share, By End-user, 2022 &amp; 2030 (%)

Figure 5 Global Nuclear Imaging Equipment Market Share, By Region, 2022 &amp; 2030 (%)

Figure 6 Global Nuclear Imaging Equipment Market Y-o-Y Growth, By Product, 2022-2030 (%)

Figure 7 Positron Emission Tomography (PET) Systems Nuclear Imaging Equipment Market Value, 2021-2030 (US$ Million)

Figure 8 Positron Emission Tomography/Computed Tomography (PET/CT) Systems Nuclear Imaging Equipment Market Value, 2021-2030 (US$ Million)

Figure 9 Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Systems Nuclear Imaging Equipment Market Value, 2021-2030 (US$ Million)

Figure 10 Single Photon Emission Computed Tomography (SPECT) Systems Nuclear Imaging Equipment Market Value, 2021-2030 (US$ Million)

Figure 11 Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) Systems Nuclear Imaging Equipment Market Value, 2021-2030 (US$ Million)

Figure 12 Global Nuclear Imaging Equipment Market Y-o-Y Growth, By Application, 2022-2030 (%)

Figure 13 Oncology Application in Global Nuclear Imaging Equipment Market Value, 2021-2030 (US$ Million)

Figure 14 Cardiology Application in Global Nuclear Imaging Equipment Market Value, 2021-2030 (US$ Million)

Figure 15 Neurology Application in Global Nuclear Imaging Equipment Market Value, 2021-2030 (US$ Million)

Figure 16 Others Application in Global Nuclear Imaging Equipment Market Value, 2021-2030 (US$ Million)

Figure 17 Global Nuclear Imaging Equipment Market Y-o-Y Growth, By End-user, 2022-2030 (%)

Figure 18 Hospitals End-user in Global Nuclear Imaging Equipment Market Value, 2021-2030 (US$ Million)

Figure 19 Imaging Centers End-user in Global Nuclear Imaging Equipment Market Value, 2021-2030 (US$ Million)

Figure 20 Academic &amp; Research Centers End-user in Global Nuclear Imaging Equipment Market Value, 2021-2030 (US$ Million)

Figure 21 Others End-user in Global Nuclear Imaging Equipment Market Value, 2021-2030 (US$ Million)

Figure 22 Global Nuclear Imaging Equipment Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 23 North America Nuclear Imaging Equipment Market Value, 2021-2030 (US$ Million)

Figure 24 Asia-Pacific Nuclear Imaging Equipment Market Value, 2021-2030 (US$ Million)

Figure 25 Europe Nuclear Imaging Equipment Market Value, 2021-2030 (US$ Million)

Figure 26 South America Nuclear Imaging Equipment Market Value, 2021-2030 (US$ Million)

Figure 27 Middle East and Africa Nuclear Imaging Equipment Market Value, 2021-2030 (US$ Million)

Figure 28 North America Nuclear Imaging Equipment Market Value, 2021-2030 (US$ Million)

Figure 29 North America Nuclear Imaging Equipment Market Share, By Product, 2022 &amp; 2030 (%)

Figure 30 North America Nuclear Imaging Equipment Market Share, By Application, 2022 &amp; 2030 (%)

Figure 31 North America Nuclear Imaging Equipment Market Share, By End-user, 2022 &amp; 2030 (%)

Figure 32 North America Nuclear Imaging Equipment Market Share, By Country, 2022 &amp; 2030 (%)

Figure 33 South America Nuclear Imaging Equipment Market Value, 2021-2030 (US$ Million)

Figure 34 South America Nuclear Imaging Equipment Market Share, By Product, 2022 &amp; 2030 (%)

Figure 35 South America Nuclear Imaging Equipment Market Share, By Application, 2022 &amp; 2030 (%)

Figure 36 South America Nuclear Imaging Equipment Market Share, By End-user, 2022 &amp; 2030 (%)

Figure 37 South America Nuclear Imaging Equipment Market Share, By Country, 2022 &amp; 2030 (%)

Figure 38 Europe Nuclear Imaging Equipment Market Value, 2021-2030 (US$ Million)

Figure 39 Europe Nuclear Imaging Equipment Market Share, By Product, 2022 &amp; 2030 (%)

Figure 40 Europe Nuclear Imaging Equipment Market Share, By Application, 2022 &amp; 2030 (%)

Figure 41 Europe Nuclear Imaging Equipment Market Share, By End-user, 2022 &amp; 2030 (%)

Figure 42 Europe Nuclear Imaging Equipment Market Share, By Country, 2022 &amp; 2030 (%)

Figure 43 Asia-Pacific Nuclear Imaging Equipment Market Value, 2021-2030 (US$ Million)

Figure 44 Asia-Pacific Nuclear Imaging Equipment Market Share, By Product, 2022 &amp; 2030 (%)

Figure 45 Asia-Pacific Nuclear Imaging Equipment Market Share, By Application, 2022 &amp; 2030 (%)

Figure 46 Asia-Pacific Nuclear Imaging Equipment Market Share, By End-user, 2022 &amp; 2030 (%)

Figure 47 Asia-Pacific Nuclear Imaging Equipment Market Share, By Country, 2022 &amp; 2030 (%)

Figure 48 Middle East &amp; Africa Nuclear Imaging Equipment Market Value, 2021-2030 (US$ Million)

Figure 49 Middle East &amp; Africa Nuclear Imaging Equipment Market Share, By Product, 2022 &amp; 2030 (%)

Figure 50 Middle East &amp; Africa Nuclear Imaging Equipment Market Share, By Application, 2022 &amp; 2030 (%)

Figure 51 Middle East &amp; Africa Nuclear Imaging Equipment Market Share, By End-user, 2022 &amp; 2030 (%)

Figure 52 Siemens Healthcare GmbH: Financials

Figure 53 GE Healthcare: Financials

Figure 54 Philips Healthcare: Financials

Figure 55 Canon Medical Systems Corp: Financials

Figure 56 Serac Imaging Systems Ltd: Financials

Figure 57 Neusoft Medical Systems Co Ltd.: Financials

Figure 58 DIGIRAD HEALTH, INC.: Financials

Figure 59 Mediso Ltd.: Financials

Figure 60 PerkinElmer: Financials

Figure 61 MILabs B.V.: Financials

Nuclear Imaging Equipment Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Nuclear Air Filtration Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 June 25

Starting from

Nuclear Medicine Radioisotopes Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 October 26

Starting from